Institutional Manager · CIK 0002043476
B Group, Inc.
DALLAS, TX · File #028-25141
Latest AUM
$135.4M
Positions
16
Top-10 Concentration
89.8%
Filings
5
Portfolio Value Over Time
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | ELI LILLY & CO | 532457108 | -22,500 | -$17.2M | $0 |
| EXITED | NVIDIA CORPORATION | 67066G104 | -75,000 | -$14.0M | $0 |
| EXITED | AKERO THERAPEUTICS INC | 00973Y108 | -232,446 | -$11.0M | $0 |
| NEW | PALISADE BIO INC | PALI | +4,500,000 | +$10.6M | $0 |
| NEW | STRUCTURE THERAPEUTICS INC | GPCR | +90,000 | +$6.3M | $0 |
| EXITED | NRX PHARMACEUTICALS INC | 629444118 | -3,000,000 | -$4.5M | $0 |
| REDUCE | APOGEE THERAPEUTICS INC | APGE | -15,000 | -$1.1M | +$1.3M |
| ADD | ADMA BIOLOGICS INC | ADMA | +45,000 | +$820,800 | +$8.6M |
| ADD | PRAXIS PRECISION MEDICINES I | PRAX | +1,737 | +$511,963 | +$7.6M |
| EXITED | GAMESQUARE HLDGS INC | 36468G103 | -250,000 | -$169,700 | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202516 pos · $135.4M
- 13F HOLDINGS REPORTQ/E Sep 202520 pos · $135.9M
- 13F HOLDINGS REPORTQ/E Jun 202517 pos · $129.9M
- 13F HOLDINGS REPORTQ/E Mar 202519 pos · $116.7M
- 13F HOLDINGS REPORTQ/E Dec 202418 pos · $163.6M
Top 16 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | ADMA BIOLOGICS INC | ADMA | 2,457,542 | $44.8M | 33.10% |
| 2 | CELLECTIS S A | CLLS | 3,281,501 | $15.9M | 11.73% |
| 3 | PALISADE BIO INC | PALI | 4,500,000 | $10.6M | 7.81% |
| 4 | TAYSHA GENE THERAPIES INC | TSHA | 1,800,556 | $9.9M | 7.31% |
| 5 | PRAXIS PRECISION MEDICINES I | PRAX | 33,237 | $9.8M | 7.23% |
| 6 | SIGHT SCIENCES INC | SGHT | 920,000 | $7.3M | 5.39% |
| 7 | ZAI LAB LTD | ZLAB | 400,000 | $7.1M | 5.21% |
| 8 | STRUCTURE THERAPEUTICS INC | GPCR | 90,000 | $6.3M | 4.62% |
| 9 | ASSEMBLY BIOSCIENCES INC | ASMB | 175,706 | $6.0M | 4.41% |
| 10 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 1,500,000 | $4.1M | 3.02% |
| 11 | SPYRE THERAPEUTICS INC | SYRE | 100,000 | $3.3M | 2.42% |
| 12 | AURA BIOSCIENCES INC | AURA | 572,576 | $3.1M | 2.30% |
| 13 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 135,000 | $3.1M | 2.29% |
| 14 | ORUKA THERAPEUTICS INC | ORKA | 75,000 | $2.3M | 1.68% |
| 15 | APOGEE THERAPEUTICS INC | APGE | 20,000 | $1.5M | 1.11% |
| 16 | REPLIMUNE GROUP INC | REPL | 50,000 | $486,000 | 0.36% |